Previous research has shown that
hesperidin, a
flavanone glycoside in orange juice, inhibits colon
carcinogenesis and that feeding double-strength orange juice delays the onset of chemically induced
mammary cancer in rats. This study determined whether feeding single-strength, pasteurized orange juice would inhibit
azoxymethane (AOM)-induced
colon cancer in male Fischer 344 rats.
Colon cancer was initiated by injecting AOM (15 mg/kg body wt) at 22 and 29 days of age. One week after the second AOM injection, orange juice replaced
drinking water for the experimental group (
n = 30). The rats were killed 28 weeks later, and
tumors were removed for histological analysis. Feeding orange juice reduced
tumor incidence by 22% (p < 0.05).
Tumor reduction was associated with a decreased labeling index and proliferation zone in the colonic mucosa.
Hesperidin, other
flavonoids,
limonin 17-beta-D-glucopyranoside, and other
limonoid glucosides are potential chemopreventive agents in orange juice that could account for the decreased colon
tumorigenesis associated with feeding orange juice.